Published in Mol Biol Rep on March 01, 1974
Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J Cell Biol (1975) 36.95
Cell-free translation of immunoglobulin messenger RNA from MOPC-315 plasmacytoma and MOPC-315 NR, a variant synthesizing only light chain. Proc Natl Acad Sci U S A (1975) 2.37
Amino acid-sequence variability at the N-terminal extra piece of mouse immunoglobulin light-chain precursors of the same and different subgroups. Biochem J (1976) 1.30
Messenger RNA of opsin from bovine retina: isolation and partial sequence of the in vitro translation product. Proc Natl Acad Sci U S A (1979) 1.25
Identification of N-terminal methionine in the precursor of immunoglobulin light chain. Initiation of translation of messenger ribonucleic acid in plants and animals. Biochem J (1976) 1.20
Amino acid sequence of the precursor region of MOPC-315 mouse immunoglobulin heavy chain. Proc Natl Acad Sci U S A (1977) 0.92
Partial amino-acid sequence of the precursor of an immunoglobulin light chain containing NH2-terminal pyroglutamic acid. Proc Natl Acad Sci U S A (1976) 0.87
Induction of rat liver metallothionein mRNA and its distribution between free and membrane-bound polyribosomes. Biochem J (1980) 0.81
The Bcl-2 protein family: arbiters of cell survival. Science (1998) 16.08
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (1988) 14.66
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (1986) 14.56
Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science (1999) 11.96
The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene (2007) 10.08
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell (1991) 8.27
Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J (1998) 7.17
Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO J (1983) 5.93
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature (1990) 5.63
N-formylmethionyl-sRNA as the initiator of protein synthesis. Proc Natl Acad Sci U S A (1966) 5.50
Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell (1991) 5.02
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A (1991) 4.72
Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J (1995) 4.68
Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion. Cell (1984) 4.41
DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell (1994) 4.22
The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J Exp Med (1988) 3.80
The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell (1986) 3.72
Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBO J (1985) 3.68
Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci U S A (1999) 3.45
Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc Natl Acad Sci U S A (1983) 3.40
Nucleotide sequence from the coat protein cistron of R17 bacteriophage RNA. Nature (1969) 3.23
Origin of the human L1 elements: proposed progenitor genes deduced from a consensus DNA sequence. Genomics (1987) 3.21
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci (2001) 3.03
Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell (2001) 3.03
On the release of the formyl group from nascent protein. J Mol Biol (1968) 3.00
Modified nucleosides and bizarre 5'-termini in mouse myeloma mRNA. Nature (1975) 2.97
Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J (1994) 2.91
Deletions are associated with somatic rearrangement of immunoglobulin heavy chain genes. Cell (1980) 2.89
Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv Cancer Res (1986) 2.84
Nucleotide sequence of N-formyl-methionyl-transfer RNA. Nature (1968) 2.82
Somatic rearrangements forming active immunoglobulin mu genes in B and T lymphoid cell lines. Proc Natl Acad Sci U S A (1980) 2.77
Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene (1997) 2.70
Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange. Cell (1984) 2.60
Structural analysis of a set of proteins resulting from a bacterial genomics project. Proteins (2005) 2.59
Expression of the immunoglobulin C mu gene in mouse T and B lymphoid and myeloid cell lines. Proc Natl Acad Sci U S A (1980) 2.57
The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J (1997) 2.44
A very large repeating unit of mouse DNA containing the 18S, 28S and 5.8S rRNA genes. Cell (1977) 2.42
Isolation and characterization of cloned human DNA fragments carrying reiterated sequences common to both autosomes and the X chromosome. Nucleic Acids Res (1981) 2.41
bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene (1993) 2.25
Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations. Nature (1985) 2.19
Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. Proc Natl Acad Sci U S A (1982) 2.16
Transgenic models of tumor development. Science (1991) 2.16
A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J (1989) 2.13
The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line. Mol Cell Biol (1995) 2.08
Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood (1999) 2.06
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. J Infect Dis (1995) 2.05
bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J (1990) 2.00
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98
Deletions in the constant region locus can account for switches in immunoglobulin heavy chain expression. Nature (1980) 1.96
Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci U S A (1998) 1.95
Sets of immunoglobulin V kappa genes homologous to ten cloned V kappa sequences: implications for the number of germline V kappa genes. J Mol Appl Genet (1981) 1.93
GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line. EMBO J (1992) 1.90
Transcripts of the immunoglobulin C mu gene vary in structure and splicing during lymphoid development. Proc Natl Acad Sci U S A (1980) 1.89
Measles antibodies in patients with multiple sclerosis and with other neurological and nonneurological diseases. Neurology (1970) 1.88
Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature (1994) 1.88
bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene (1996) 1.87
Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol (1990) 1.86
Molecular cloning of seven mouse immunoglobulin kappa chain messenger ribonucleic acids. Biochemistry (1980) 1.82
In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ (2008) 1.81
Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. Proc Natl Acad Sci U S A (1990) 1.80
Expression of multiple homeobox genes within diverse mammalian haemopoietic lineages. EMBO J (1988) 1.79
The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J (2000) 1.79
Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 1.76
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis. Cell Death Differ (2009) 1.75
Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes. J Virol (1988) 1.75
Expression of Hox-2.4 homeobox gene directed by proviral insertion in a myeloid leukemia. Nucleic Acids Res (1989) 1.74
Intervening sequences divide the gene for the constant region of mouse immunoglobulin mu chains into segments, each encoding a domain. Proc Natl Acad Sci U S A (1980) 1.73
Cloned pairs of variable region genes for immunoglobulin heavy chains isolated from a clone library of the entire mouse genome. Proc Natl Acad Sci U S A (1979) 1.71
Inclusion bodies in measles encephalitis. JAMA (1966) 1.71
Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. Blood (1998) 1.70
Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas. Mol Cell Biol (1986) 1.70
Simple method for stabilising umbilical catheters. Arch Dis Child (1979) 1.67